Trial site
Monterrey
- 15running trials
- 5closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia4 trials
- Familial hypercholesterolaemia3 trials
- Lupus (SLE)3 trials
- Childhood cancers2 trials
- Hidradenitis suppurativa2 trials
- IgA nephropathy2 trials
- Immune thrombocytopenia (ITP)2 trials
- Myeloproliferative neoplasms2 trials
- Systemic sclerosis (scleroderma)2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- Coronary artery disease1 trial
- and 5 more
- Phase
- Phase 313 trials
- Phase 24 trials
- Phase 42 trials
- Phase 1/21 trial
- Status
- Active, not recruiting11 trials
- Completed4 trials
- Recruiting4 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals20 trials
Running trials
Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- High blood pressure1 recruiting
- IgA nephropathy1 recruiting
- Lupus (SLE)1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
Terminated
Completed
Completed
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Site data: ClinicalTrials.govUpdated 17 Nov 2026